Every cancer patient enters remission after drug trial, study reveals

NEW YORK POST:

A recent drug trial administered to a handful of cancer patients had the surprising result of eliminating the disease in every participant involved.

The study was conducted on 18 rectal cancer patients at Memorial Sloan Kettering Cancer Center in Manhattan and had a 100 percent success rate, according to a paper published Sunday in the New England Journal of Medicine.

“I believe this is the first time this has happened in the history of cancer,” Dr. Luis A. Diaz Jr, the author of the paper, told the New York Times.

READ MORE

Join now!